Prof. Dr. Ahmet Öztürk
Hematology
About Ahmet Öztürk
Prof. Ahmet Öztürk is a seasoned medical professional and professor with a distinguished career in clinical practice, education, and leadership. He earned his professorship in 2002 at GATA Haydarpaşa Training Hospital, where he developed a strong foundation in medical teaching and patient care. Since 2016 he has been affiliated with Acıbadem Health Group, contributing his expertise to a leading private healthcare organization. He is an active member of the Turkish Hematology Association, participating in the professional community and staying current with advances in hematology. Known for a commitment to clinical excellence and medical education, Prof. Öztürk brings extensive experience and respected leadership to his field.
Subspecialties
- Acute myeloid leukemia
- Myelodysplastic syndrome
- Idiopathic thrombocytopenic purpura
- Hemophilia
- Non-Hodgkin lymphoma
- Bone marrow transplantation
- Etoposide, thioguanine and cytarabine chemotherapy
- Helicobacter pylori eradication therapy for idiopathic thrombocytopenic purpura
Education
- 2002 GATA Haydarpaşa Training Hospital / Professor
- 1997 GATA Haydarpaşa Training Hospital / Associate Professor
- 1995 Gulhane Military Medical Academy Hematology
- 1995 GATA Haydarpaşa Training Hospital / Assistant Professor
- 1992 Gulhane Military Medical Academy Internal Medicine
- 1984 Gulhane Military Medical Academy Faculty of Medicine
Experience
- 2016 Acibadem Health Group
- 2002 – 2009 GATA Haydarpaşa Training Hospital / Hematology Clinic Chief
- 1997 – 1998 Fred Hutchinson Cancer Research Center, Bone Marrow Transplant Center
- 1985 – 1987 Flight Medicine
Professional Memberships
- Turkish Hemotology Association
Selected Publications
- Effects of corticosteroids on hemostasis and pulmonary arterial pressure during chronic obstructive pulmonary disease exacerbation. Respiration Kunter E,İlvan A,Özmen N,Demirer E,Öztürk A,Avşar K,Sayan Ö,Kartaloğlu Z
- Result of treatment of acute myeloid leukemia and myelodysplastic syndrome with etoposide, thioguanine, cytarabine (ETC) in elderly patients. Turk J Hematol 23;193-196,2006 A.Öztürk,A.Erikçi,Ö.Sayan.
- A role for leptin in idiopathic thrombocytopenic purpura? Platelets.17,501-502,2006. Akyol Alev, Ozturk Ahmet, Sayan Ozkan
- Investigation of the efficacy of irinotecan in patients with fluorosil-resistant advanced colorectal cancer. Clinical Sciences and Medicine O.Türken,M.Yaylacı,G.Kandemir,A.Öztürk,Ö Sayan
- The efficacy of helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura the first study in Turkey. Acta Hematologica 116,146-149,2006 O.Sayan,Erikçi A,Ozturk A
- Pretreatment haemoglobin concentration is a prognostic factor in patients with early stage breast cacer. J Int Med Res. 33; 319-328,2005 Kandemir E.G,Mayadağlı A,Türken O,Yaylacı M,Özturk A.
- The seroprevelance of viral infections and their effects on immune system in Turkish Haemophilic patients. Haemophilia 9,655-656, 2003 O.Türken,E.Solmazgül,S.Sipahi,A.Öztürk,H.Öztürkeri.
- Prevalence and prognostic value of c-erbB2 expression in non small cell lung cancer. Neoplasma 50,257-261,2003 O.Türken,E.Kunter,H.Çermik,T.Işıtmangil,M.Yaylacı,A.Öztürk.
- Breast cancer in association with thyroid disorders. Breast Cancer Reserch 5,110-113,2003. O.Türken,Y.Narin,S.Demirbaş,M:E.Önde,Ö.Sayan,E.G.Kandemir, M.Yaylacı, A.Öztürk
- Evaluation of CA-125 as a prognostic marker in Non-Hodgkin’s Lymphoma. Turkish Journal of Oncology 17:151-154,2002. O.Türken,Y.Narin,G.Kandemir,M.Yaylacı,A.Öztürk,B.Orhan
- Prognostic significance of c-erb B-2 (HER 2/neu) Expression in Early Stage Breast Cancer and its relationship with other prognostic factors Turkish Journal of Oncology 17:166-170,2002 O.Türken , Y.Kayacı , G.Kandemir , M.Yaylacı ,A.Öztürk N.Üskent
Schedule your appointment with Prof. Dr. Ahmet Öztürk
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.